Karyopharm Therapeutics
KPTI
KPTI
134 hedge funds and large institutions have $334M invested in Karyopharm Therapeutics in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 58 increasing their positions, 34 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
134
Holders Change
-19
Holders Change %
-12.42%
% of All Funds
2.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
58
Reduced
34
Closed
33
Calls
$2.28M
Puts
$8.13M
Net Calls
-$5.85M
Net Calls Change
+$3.66M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$46.7M |
| 2 |
Renaissance Technologies
New York
|
$2.88M |
| 3 |
UBS Group
Zurich,
Switzerland
|
$3.54M |
| 4 |
Two Sigma Investments
New York
|
$6.38M |
| 5 |
Morgan Stanley
New York
|
$11M |
